Martin Simard, researcher and assistant director of the oncology division for the CHU de Québec Université Laval – Research Centre and professor at the Faculty of Medicine of Laval University, announced on June 19th the creation of the Fund for cancer research in Quebec, which is attached to the Quebec CHU Foundation. He also unveiled the launch of their first fundraising campaign: Ensemble, nous pouvons le vaincre! (Together, we can conquer cancer!).
During this announcement, Mr. Simard yielded the floor to Patrice Gilbert, CEO of PetalMD, who will be the Honorary President of this first event for the fundraising campaign. The fundraising evening will be held October 10th, 2019, at the Quebec City Convention Centre, who is also one of the event sponsors.
"I am very proud to see that in Quebec, we have incredible talent and internationally renowned researchers working to revolutionize the health system. We must work together to ensure that health remains a priority in Quebec, both in terms of technology and research. That’s why I’m excited to join this first fundraising campaign as Honorary President."
Patrice Gilbert, CEO pf PetalMD
This first event is already accumulating a lot of enthusiasm as major ambassadors are agreeing to join Mr. Gilbert; in particular Julie Bédard, President and Chief Executive Officer for the Quebec Chamber of Commerce and Industry and Carl Viel, President and CEO of Québec International.
In 2018, Statistics Canada stated that about one in two Canadians will develop cancer within their lifetime. Attached to the Quebec CHU Foundation, the Fund will raise money that will be invested 100% in cancer research being done here in Quebec City.
"With this fund, we will be able to amass donations so that teams can acquire state-of-the-art equipment, recruit researchers and students from around the world, and develop innovative research projects that will lead to significant advances in our fight against cancer. The opportunity to bring together researchers, physicians and patients in one place through the construction of a brand new research centre attached to the new hospital complex at the Quebec CHU - Laval University will establish here, in Quebec, an extraordinary centre for cancer research for the benefit of our population."
Martin Simard, Researcher and assistant director of the oncology division for the CHU de Québec Université Laval – Research Centre
We would like to highlight the presence at the press conference of Ms. Julie Bédard, President and Chief Executive Officer of the Québec City Chamber of Commerce and Industry, Mr. Carl Viel, President and CEO of Quebec International, Mr. Serge Rivest, Ph.D., Director of the CHU – Laval University Research Centre, and Ms. Marie-Andrée Leclerc, Community Development Consultant - Community Initiatives at the Quebec CHU Foundation.
If you wish to contribute to cancer research done here in Quebec City, as well as participate in the creation of local collective prosperity, make sure to book your ticket for this event, which will take place on October 10th, 2019, by registering here.
The CHU de Québec Université Laval – Research Centre, is the largest Francophone centre for health research in North America. It has more than 500 research teams, including about 60 in the oncology division. These researchers are dedicated to solving complex scientific issues related to cancer for the benefit of patients and society.
The objective of the new Cancer Research Fund in Quebec City is to support the innovative research of our researchers here, which will be done in a brand-new building that is part of the new hospital complex of the Quebec CHU - Laval University situated at the Hôpital de l'Enfant-Jésus Child Jesus Hospital.
An efficient, influential and innovative philanthropic leader, the Quebec CHU Foundation, is the largest hospital foundation in the province. It makes a difference for people’s health, from birth to end of life, by financially supporting the humanization of health care for the largest organization devoted to specialized care in Quebec, the Quebec CHU - Laval University. This means the CHU can offer better quality medical services, while contributing to research and teaching, as well as remaining at the cutting edge of technological innovations.